# UltraSight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ultrasight

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, US
- Website: www.ultrasight.com
- Total disclosed funding: $37M
- Latest round: Series B (Sep 23, 2026)
- Investors on record: 11

## About

Based in Rehovot, Israel, and Co-founded in 2018 by Yaron Lipman , (CTO) Itay Kezurer and (CMO) Dr. Achi Ludomirsky ,  UltraSight Inc. develops software for cardiac ultrasound imaging and image guidance. The company was previously known as On-Sight Medical. In September 2026, the company raised USD 24 million from Alive HealthTech Growth Fund, Deep Insight, Star51 Capital, Connecticut Innovations , eHealth Ventures, Mayo Clinic Ventures, NYU and Iron Nation.
UltraSight develops software for cardiac ultrasound imaging and image guidance. Its offerings include artificial intelligence-based guidance software that assists healthcare professionals in acquiring cardiac ultrasound images and supports ultrasound imaging workflows. The software can be used with compatible ultrasound systems for cardiac imaging applications.
UltraSight generates revenue through the licensing and deployment of cardiac ultrasound software for healthcare providers and medical institutions. Revenue is derived from software subscriptions, licensing agreements, and commercial partnerships associated with its ultrasound imaging solutions.
The company plans to utilize the September 2026 funding to expand its operations in the United States, develop cardiac imaging workflows for intensive care and circulatory support settings, and support partnerships for its ultrasound products.

## Funding rounds

- Series B, Sep 23, 2026, $24M — Mayo Clinic Ventures, Connecticut Innovations, NYU Venture Capital, eHealth Ventures, ALIVE, Deep Insight, Iron Nation, Star51 Capital
- Series B, May 11, 2021, $13M — Weizmann Global Endowment Management Trust, Atain Insurance Company, Yozma Group Korea

## Investors

- Weizmann Global Endowment Management Trust — Series B
- Atain Insurance Company — Series B
- Yozma Group Korea (https://capitalatlas.ai/funds/yozma-group-korea) — Series B
- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Series B
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series B
- NYU Venture Capital (https://capitalatlas.ai/funds/nyu-venture-capital) — Series B
- eHealth Ventures (https://capitalatlas.ai/funds/ehealth-ventures) — Series B
- ALIVE — Series B
- Deep Insight (https://capitalatlas.ai/funds/deep-insight) — Series B
- Iron Nation (https://capitalatlas.ai/funds/iron-nation) — Series B
- Star51 Capital (https://capitalatlas.ai/funds/star51-capital) — Series B